The extraordinary general meeting of Hemfosa on September 13, 2018 resolved to distribute all of the shares in the subsidiary Nyfosa AB (“Nyfosa”) to the ordinary shareholders of Hemfosa. The Board of Directors was authorized to determine the record date for the distribution and the record date has now been set to November 21, 2018. The first day of trading in Nyfosa shares is expected to be November 23, 2018.
Nasdaq Stockholm’s Listing Committee has approved that Nyfosa’s shares are admitted to trading on Nasdaq Stockholm. The approval is conditional on that customary conditions are met, including, inter alia, the approval and registration of a prospectus by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen).
The shares in Nyfosa will be distributed to Hemfosa’s ordinary shareholders in proportion (1:1) to each individual ordinary shareholder’s holding in Hemfosa on the record date for the distribution. Aside from being registered as an ordinary shareholder in Hemfosa on the record date for the distribution, shareholders are not required to take any further actions in order to receive shares in Nyfosa. No offering or issue of new shares will therefore be conducted in connection with the distribution of Nyfosa to Hemfosa’s ordinary shareholders. The shares will be traded in the Large Cap segment under the ticker symbol NYF and ISIN code (SE0011426428).
“Nyfosa is a transaction-intensive and opportunistic property company targeting the best possible transactions. We start with a solid commercial property portfolio of SEK 15.4 billion and we are in every way ready to build a new, cash-flow driven company in the Swedish property market. The ambition is to grow rapidly and with Nyfosa’s experienced team and the right resources we have the conditions in place to reach our goals. I am proud that Nyfosa is now taking the step to become an independent listed company on Nasdaq Stockholm,” says Jens Engwall, CEO of Nyfosa.
For further information, refer to the prospectus prepared for the admission to trading of Nyfosa’s shares on Nasdaq Stockholm. The prospectus is expected to be published on Wednesday, November 7, 2018 and will be available on Nyfosa’s (www.nyfosa.se) and Hemfosa’s (www.hemfosa.se) websites.
Timetable for distribution and listing
November 19, 2018 Final date for trading in Hemfosa’s ordinary share with the right to distribution of shares in Nyfosa
November 20, 2018 Hemfosa’s ordinary shares are traded excluding the right to distribution of shares in Nyfosa
November 21, 2018 Record date for receiving shares in Nyfosa
November 23, 2018 Expected first day of trading in Nyfosa’s shares on Nasdaq Stockholm
SEB Corporate Finance and Swedbank Corporate Finance are financial advisors and Advokatfirman Cederquist is legal advisor to Nyfosa in connection with the listing on Nasdaq Stockholm.
For further information, please contact:
Bengt Kjell, Chairman of the Board of Hemfosa and Nyfosa, mobile +46 70 594 53 98
Caroline Arehult, VD Hemfosa, mobil +46 70 553 80 26, [email protected]
For questions regarding Nyfosa:
Jens Engwall, CEO Nyfosa, [email protected], mobile +46 70 690 65 50